NeurologyLive® Friday 5 — March 29, 2024

News
Article

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending March 29, 2024.

Welcome to NeurologyLive®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive®'s widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

1: Enhancing Multidisciplinary Care for Neuromuscular Disorders: Amanda Peltier, MD

The professor of neurology at Vanderbilt University Medical Center talked about the importance of multidisciplinary care centers to improve accessibility and quality of care for patients with neuromuscular disorders. [WATCH TIME: 5 minutes]

Enhancing Multidisciplinary Care for Neuromuscular Disorders: Amanda Peltier, MD

2: Navigating Treatment Decision-Making in Multiple Sclerosis

In a paradigm with many options, once multiple sclerosis is confirmed as a patient’s diagnosis, physicians are left with 1 question: What do we choose for long-term treatment?

Navigating Treatment Decision-Making in Multiple Sclerosis

3: TSC Alliance® Highlights Awareness for Purple Day 2024

Purple Day 2024 allows the TSC Alliance to highlight the importance of epilepsy awareness since tuberous sclerosis complex (TSC) is the leading genetic cause of seizures.

TSC Alliance® Highlights Awareness for Purple Day 2024

4: NeuroVoices: Danielle Andrade, MD, MSc, FRCPC, on Challenges in the Transition from Pediatric to Adult Epilepsy Care

In this week's NeuroVoices Q&A, the director of the Adult Genetic Epilepsy Program at the University of Toronto talked about the significant challenges posed by transitioning patients with epilepsy from pediatric to adult care settings.

NeuroVoices: Danielle Andrade, MD, MSc, FRCPC, on Challenges in the Transition from Pediatric to Adult Epilepsy Care

5: Presentation of Myasthenia Gravis (MG)

In episode 1 of the "Optimizing Outcomes in Myasthenia Gravis Through Personalized Care and Treatment Selection" video series, expert neurologists discuss the presentation of myasthenia gravis, focusing on the variability of symptoms from patient to patient.

Presentation of Myasthenia Gravis (MG)
Related Videos
Kevin Church, PhD
Merit Cudkowicz, MD, MSc
Jessica Ailani, MD
Frederic Schaper, MD, PhD
Jaime Imitol, MD
© 2024 MJH Life Sciences

All rights reserved.